Ticker
  • Companies
  • RNS
  • AI Chat
  • Research
  • Indices
  • Ticker TV
  • Events
  • Commodities
  • Currencies
Ticker
⌘K
Developer PortalNewsServices
/Equities/XLON/BPCR
OverviewShare PriceRNSTradesShort InterestDirectorsHoldingsBuybacksTrust Data
Biopharma Credit PLC logo
Biopharma Credit PLC
/Equities/XLON/BPCR
OverviewShare PriceRNSTradesShort InterestDirectorsHoldingsBuybacksTrust Data
Biopharma Credit PLC logo

Biopharma Credit PLC

Loading price data...
--
--

Price Chart

Open
0.94
High
0.94
Low
0.94
Close
0.94
Change
+0.00 (0.00%)
Volume
641,680

Recent RNS announcements

22 Apr 202616:10:47Dividend Declaration
16 Apr 202617:59:38Director/PDMR Shareholding
14 Apr 202617:44:02Transaction in Own Shares
13 Apr 202617:07:42Transaction in Own Shares
10 Apr 202617:36:38Transaction in Own Shares

Annual Reports

25 Mar 2026Annual Report and Financial Statements for the year ended 31 December 2025
1 Jan 2026Annual_Report_2025
10 Apr 2025Annual Financial Report

Directors (7)

DW
Duncan William Allan BudgeNon-Executive Director
9 yrs 6 mos
CM
Colin Michael BondNon-Executive Director
9 yrs 5 mos
HA
Harry Abraham HymanExecutive Director
9 yrs 2 mos
SM
Stephanie Marie LeouzonNon-Executive Director
7 yrs 4 mos
RS
Rolf SoderstromExecutive Director
5 yrs 7 mos

Company details

BioPharma Credit PLC is a unique investment firm in London that specializes in providing debt financing to companies in the life sciences industry. The company aims to generate consistent and sustainable income for its shareholders by investing in this sector for the long term.

Industry
Financials
Sector
Financial Services
LEI
213800AV55PYXAS7SY24
Region
Europe
Admission date
27 Mar 2017
Website
bpcruk.com

Investment Trust · as at 28 Feb 2026

NAV per Share
100.05p
Discount/Premium
-99.1%

NAV History

Dec 2023–Feb 2026 · Daily

Shares details

Shares in issue
1,126,217,778
Total Voting Rights
1,126,217,778
Treasury Shares
247,714,289
Last updated: 23 April 2026

Recent Buybacks

20/08/2025
100,000£886
20/08/2025
100,000£886
11/04/2025
50,000£41,380
08/04/2025
215,000£181,847
07/04/2025
35,000£29,743

Instrument details

ISIN
GB00BDGKMY29
Exchange
XLON
Market
Main Market
Market Segment
STMM
Market Sector
F25T
Security Description
Ordinary Shares of USD0.01 each; fully paid
Listing Category
Closed-ended investment funds
Loading price data...
--
--

Price Chart

Open
0.94
High
0.94
Low
0.94
Close
0.94
Change
+0.00 (0.00%)
Volume
641,680

Recent RNS announcements

22 Apr 202616:10:47Dividend Declaration
16 Apr 202617:59:38Director/PDMR Shareholding
14 Apr 202617:44:02Transaction in Own Shares
13 Apr 202617:07:42Transaction in Own Shares
10 Apr 202617:36:38Transaction in Own Shares

Annual Reports

25 Mar 2026Annual Report and Financial Statements for the year ended 31 December 2025
1 Jan 2026Annual_Report_2025
10 Apr 2025Annual Financial Report

Directors (7)

DW
Duncan William Allan BudgeNon-Executive Director
9 yrs 6 mos
CM
Colin Michael BondNon-Executive Director
9 yrs 5 mos
HA
Harry Abraham HymanExecutive Director
9 yrs 2 mos
SM
Stephanie Marie LeouzonNon-Executive Director
7 yrs 4 mos
RS
Rolf SoderstromExecutive Director
5 yrs 7 mos

Company details

BioPharma Credit PLC is a unique investment firm in London that specializes in providing debt financing to companies in the life sciences industry. The company aims to generate consistent and sustainable income for its shareholders by investing in this sector for the long term.

Industry
Financials
Sector
Financial Services
LEI
213800AV55PYXAS7SY24
Region
Europe
Admission date
27 Mar 2017
Website
bpcruk.com

Investment Trust · as at 28 Feb 2026

NAV per Share
100.05p
Discount/Premium
-99.1%

NAV History

Dec 2023–Feb 2026 · Daily

Shares details

Shares in issue
1,126,217,778
Total Voting Rights
1,126,217,778
Treasury Shares
247,714,289
Last updated: 23 April 2026

Recent Buybacks

20/08/2025
100,000£886
20/08/2025
100,000£886
11/04/2025
50,000£41,380
08/04/2025
215,000£181,847
07/04/2025
35,000£29,743

Instrument details

ISIN
GB00BDGKMY29
Exchange
XLON
Market
Main Market
Market Segment
STMM
Market Sector
F25T
Security Description
Ordinary Shares of USD0.01 each; fully paid
Listing Category
Closed-ended investment funds
Share Price0.94
Day Change+0.00(+0.00%)
Market Cap$1.06bn
Today 15:21
Market closed
Share Price0.94
Day Change+0.00(+0.00%)
Market Cap$1.06bn
Today 15:21
Market closed